Literature DB >> 17981884

Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.

Tom Yang1, Cynthia C Nast, Ashley Vo, Stanley C Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17981884     DOI： 10.1093/ndt/gfm592

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  17 in total

1.  The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy.

Authors:  Landon C Brown; Meghan A Jobson; Fernanda Payan Schober; Emily H Chang; Ronald J Falk; Patrick H Nachman; William F Pendergraft
Journal:  Am J Nephrol       Date:  2017-03-18       Impact factor: 3.754

2.  Single low-dose rituximab for the treatment of steroid-resistant nephrotic syndrome with acute kidney injury.

Authors:  Eijin Ashikaga; Susumu Uda; Kazuhisa Kamata; Yasuto Shikida; Takashi Inoue; Yoshihiro Kuno; Atsushi Yao; Mari Nakamura; Keiko Kai
Journal:  CEN Case Rep       Date:  2016-03-25

3.  American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.

Authors:  Fernando C Fervenza; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

Review 4.  Rituximab and minimal change nephrotic syndrome: a therapeutic option.

Authors:  Takashi Takei; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-05-26       Impact factor: 2.801

5.  Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.

Authors:  Andreas Kronbichler; Paul König; Martin Busch; Gunter Wolf; Gert Mayer; Michael Rudnicki
Journal:  Wien Klin Wochenschr       Date:  2013-04-27       Impact factor: 1.704

6.  Rituximab efficiency in children with steroid-dependent nephrotic syndrome.

Authors:  Anne-Laure Sellier-Leclerc; Marie-Alice Macher; Chantal Loirat; Valérie Guérin; Hervé Watier; Michel Peuchmaur; Véronique Baudouin; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2010-03-18       Impact factor: 3.714

7.  Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis.

Authors:  Gema Fernandez-Fresnedo; Alfonso Segarra; Ester González; Simona Alexandru; Ramon Delgado; Natalia Ramos; Jesús Egido; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 8.237

8.  Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children.

Authors:  Koichi Kamei; Shuichi Ito; Kandai Nozu; Shuichiro Fujinaga; Makiko Nakayama; Mayumi Sako; Mari Saito; Maki Yoneko; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

9.  Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.

Authors:  Megha Suri; Kim Tran; Ajay P Sharma; Guido Filler; Joanne Grimmer
Journal:  Int Urol Nephrol       Date:  2008-05-20       Impact factor: 2.370

Review 10.  Monoclonal antibodies for podocytopathies: rationale and clinical responses.

Authors:  Maddalena Marasà; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.